Jade Biosciences (JBIO) Retained Earnings (2020 - 2026)
Jade Biosciences posted quarterly Retained Earnings of -$342000.0 for Q1 2026, down 784.0% year-on-year from $50000.0 in Q1 2025, and down 365.12% on a QoQ basis from $129000.0 in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Retained Earnings data on file, last reported at -$342000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 784.0% year-over-year to -$342000.0; the trailing twelve-month figure through Mar 2026 stood at -$342000.0 (down 784.0% YoY), and the FY2025 full-year result was $129000.0, up 100.27% from the prior year.
- Retained Earnings for Q1 2026 stood at -$342000.0, down from $129000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $129000.0 in Q4 2025 and bottomed at -$227.6 million in Q3 2024.
- The 5-year median for Retained Earnings is -$72.9 million (2022), against an average of -$83.8 million.
- The widest annual swing landed in 2024, when Retained Earnings plunged 94691.48%; it then surged 251.52% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$87.9 million in 2022, then plunged by 85.91% to -$163.4 million in 2023, then surged by 71.25% to -$47.0 million in 2024, then surged by 100.27% to $129000.0 in 2025, then plunged by 365.12% to -$342000.0 in 2026.
- The last three Retained Earnings figures came in at -$342000.0 (Q1 2026), $129000.0 (Q4 2025), and -$142.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -342,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -342,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | -142.46 Mn |
| Jun 30, 2025 | -117.28 Mn |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | -46.98 Mn |
| Sep 30, 2024 | -227.62 Mn |
| Jun 30, 2024 | -211.39 Mn |
| Mar 31, 2024 | -33,000.00 |
| Dec 31, 2023 | -163.42 Mn |
| Sep 30, 2023 | -143.01 Mn |
| Jun 30, 2023 | -223,000.00 |
| Mar 31, 2023 | -104.42 Mn |
| Dec 31, 2022 | -87.90 Mn |
| Sep 30, 2022 | -72.88 Mn |
| Jun 30, 2022 | -59.29 Mn |
| Mar 31, 2022 | -47.30 Mn |
| Dec 31, 2021 | -36.39 Mn |
| Sep 30, 2021 | -28.17 Mn |
| Jun 30, 2021 | -21.99 Mn |
| Dec 31, 2020 | -13.41 Mn |